NCT01766232

Brief Summary

Epiphora, or uncontrolled tearing of the eyes, represents a common presenting complaint of patients seen by ophthalmologists. Epiphora may be due to non-obstructive causes, such as tear hypersecretion or functional tear pump failure, or obstructive causes. Functional tear pump failure may result from malposition of the eyelids, such as an abnormal out-turning (ectropion) or in-turning (entropion) of the eyelid. Currently methods to diagnose partial nasolacrimal duct obstruction are purely qualitative in nature. Our research goal is to quantitatively measure the pressure generated during conventional probing and irrigation (P\&I), and to measure the resistance to irrigation of the nasolacrimal drainage system. The investigators will measure the pressure generated during conventional P\&I using a disposable in-line pressure transducer. In addition, the investigators will use a syringe pump to deliver a constant flow rate of saline through a nasolacrimal cannula and measure the steady state irrigation pressure using the in-line transducer and digital pressure monitor. Resistance can be directly calculated from the known flow rate and pressure measurements. The investigators will compare both the pressure generated during P\&I and the lacrimal drainage resistance between patients with lacrimal drainage obstruction and controls patients with no obstruction (functional tear pump failure) as determined by clinical exam. Clinical applications for measuring lacrimal drainage resistance include quantifying partial nasolacrimal duct obstruction, guiding the choice of surgical procedure, and determining the success of lacrimal drainage procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

May 13, 2011

Completed
1.7 years until next milestone

First Posted

Study publicly available on registry

January 11, 2013

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

February 19, 2015

Status Verified

February 1, 2015

Enrollment Period

5.8 years

First QC Date

May 13, 2011

Last Update Submit

February 17, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lacrimal drainage resistance

    one-time clinical measurement

Secondary Outcomes (1)

  • Pressure generated during nasolacrimal duct irrigation

    one-time clinical measurement

Study Arms (2)

Obstructed nasolacrimal drainage group

This group of patients is clinically identified as having epiphora due to an obstruction of the lacrimal drainage system.

Ectropion group

This group of patients is clinically determined to have functional epiphora due to ectropion and a patent lacrimal drainage system.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients presenting to the oculoplastics service with epiphora.

You may qualify if:

  • Adult patients (18 years and older) who present for evaluation of epiphora due to obstructed causes, and control patients who present for evaluation of epiphora due to non-obstructed functional causes, who have been recommended for traditional probing and irrigation

You may not qualify if:

  • Active infection
  • Punctal stenosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Cole Eye Institute

Cleveland, Ohio, 44195, United States

Location

Related Publications (6)

  • Kuchar A, Steinkogler FJ. Antegrade balloon dilatation of nasolacrimal duct obstruction in adults. Br J Ophthalmol. 2001 Feb;85(2):200-4. doi: 10.1136/bjo.85.2.200.

    PMID: 11159486BACKGROUND
  • Mills DM, Meyer DR. Acquired nasolacrimal duct obstruction. Otolaryngol Clin North Am. 2006 Oct;39(5):979-99, vii. doi: 10.1016/j.otc.2006.07.002.

    PMID: 16982258BACKGROUND
  • Perry JD, Maus M, Nowinski TS, Penne RB. Balloon catheter dilation for treatment of adults with partial nasolacrimal duct obstruction: a preliminary report. Am J Ophthalmol. 1998 Dec;126(6):811-6. doi: 10.1016/s0002-9394(98)00278-5.

    PMID: 9860005BACKGROUND
  • Stanley CF, Masri FA. Instrument to test patency of lacrimal drainage system. J Clin Eng. 1991 Jan-Feb;16(1):57-60. doi: 10.1097/00004669-199101000-00014.

    PMID: 10109831BACKGROUND
  • Tsirbas A, Davis G, Wormald PJ. Mechanical endonasal dacryocystorhinostomy versus external dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg. 2004 Jan;20(1):50-6. doi: 10.1097/01.IOP.0000103006.49679.23.

    PMID: 14752311BACKGROUND
  • Tucker SM, Linberg JV, Nguyen LL, Viti AJ, Tucker WJ. Measurement of the resistance to fluid flow within the lacrimal outflow system. Ophthalmology. 1995 Nov;102(11):1639-45. doi: 10.1016/s0161-6420(95)30815-9.

    PMID: 9098256BACKGROUND

MeSH Terms

Conditions

Lacrimal Apparatus DiseasesLacrimal Duct ObstructionEctropion

Condition Hierarchy (Ancestors)

Eye DiseasesEyelid Diseases

Study Officials

  • Julian D Perry, MD

    Cleveland Clinic Cole Eye Institute

    PRINCIPAL INVESTIGATOR
  • Brian Costin, MD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 13, 2011

First Posted

January 11, 2013

Study Start

April 1, 2009

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

February 19, 2015

Record last verified: 2015-02

Locations